W.R. Berkley Corp’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

W.R. Berkley Corp’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-47,010	Closed	-$2.47M	–	256
2020 Q3	$2.47M	Buy	+47,010	New	+$1.95M	0.36%	52

W.R. Berkley Corp's MNTA Position: Q4 2020 in Review

W.R. Berkley Corp sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 47,010 shares — an estimated $2.47M sold.

W.R. Berkley Corp first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $2.47M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

W.R. Berkley Corp reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
W.R. Berkley Corp sold 47,010 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $2.47M.
W.R. Berkley Corp first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
W.R. Berkley Corp's Momenta Pharmaceuticals, Inc. position peaked at $2.47M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on W.R. Berkley Corp's 13F filing for Q4 2020, filed 16 Feb 2021.